These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathophysiology of chorea and bradykinesia in Huntington's disease. Berardelli A; Noth J; Thompson PD; Bollen EL; Currà A; Deuschl G; van Dijk JG; Töpper R; Schwarz M; Roos RA Mov Disord; 1999 May; 14(3):398-403. PubMed ID: 10348461 [TBL] [Abstract][Full Text] [Related]
3. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Glass M; Dragunow M; Faull RL Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533 [TBL] [Abstract][Full Text] [Related]
4. [Current perspectives in the treatment of Huntington's chorea]. Kuran W Neurol Neurochir Pol; 2002; 36(4):757-65. PubMed ID: 12418139 [TBL] [Abstract][Full Text] [Related]
7. [Huntington's chorea and neurofibromatosis (von Recklinghausen's disease). Concurrence of two generations of a family with inherited Huntington's chorea]. Dörstelmann D; Kerschensteiner M; Markus E; Sturm KW Z Neurol; 1971 Apr; 199(1):39-45. PubMed ID: 4102748 [No Abstract] [Full Text] [Related]
9. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Rosenblatt A; Leroi I Psychosomatics; 2000; 41(1):24-30. PubMed ID: 10665265 [TBL] [Abstract][Full Text] [Related]
10. A clinico-genetic study of psychiatric disorder in Huntington's chorea. Watt DC; Seller A Psychol Med; 1993; Suppl 23():1-46. PubMed ID: 8108531 [TBL] [Abstract][Full Text] [Related]
11. Memantine administration prevented chorea movement in Huntington's disease: a case report. Saigoh K; Hirano M; Mitsui Y; Oda I; Ikegawa A; Samukawa M; Yoshikawa K; Yamagishi Y; Kusunoki S; Nagai Y J Med Case Rep; 2023 Oct; 17(1):431. PubMed ID: 37840138 [TBL] [Abstract][Full Text] [Related]
12. Abnormal eye movements in three types of chorea. Attoni T; Beato R; Pinto S; Cardoso F Arq Neuropsiquiatr; 2016 Sep; 74(9):761-766. PubMed ID: 27706426 [TBL] [Abstract][Full Text] [Related]
13. Huntington's disease. Kent A Nurs Stand; 2004 Apr 21-27; 18(32):45-51; quiz 52-3. PubMed ID: 15132037 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease. Alberch J; Pérez-Navarro E; Canals JM Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278 [TBL] [Abstract][Full Text] [Related]
15. [Huntington's disease]. Heiberg A Tidsskr Nor Laegeforen; 2008 Oct; 128(19):2214-7. PubMed ID: 18846148 [TBL] [Abstract][Full Text] [Related]
16. Huntington's disease: Managing neuropsychiatric symptoms in Huntington's disease. Loi SM; Walterfang M; Velakoulis D; Looi JC Australas Psychiatry; 2018 Aug; 26(4):376-380. PubMed ID: 29687724 [TBL] [Abstract][Full Text] [Related]
17. [Neuropsychiatric aspects of Huntington chorea. Presentation of 2 cases and review of the literature]. Tost H; Schmitt A; Brassen S; Wendt CS; Braus DF Nervenarzt; 2004 Mar; 75(3):258-66. PubMed ID: 15021927 [TBL] [Abstract][Full Text] [Related]
18. Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture. Martin JB Neurology; 1984 Aug; 34(8):1059-72. PubMed ID: 6146951 [TBL] [Abstract][Full Text] [Related]
19. Echogenicity of basal ganglia structures in different Huntington's disease phenotypes. Saft C; Hoffmann R; Strassburger-Krogias K; Lücke T; Meves SH; Ellrichmann G; Krogias C J Neural Transm (Vienna); 2015 Jun; 122(6):825-33. PubMed ID: 25503829 [TBL] [Abstract][Full Text] [Related]
20. Hereditary haemochromatosis is unlikely to cause movement disorders--a critical review. Russo N; Edwards M; Andrews T; O'Brien M; Bhatia KP J Neurol; 2004 Jul; 251(7):849-52. PubMed ID: 15258788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]